Mixed Topics
News
FDA okays emergency use for Impella RP in COVID-19 right heart failure
From the Journals
Cancer risk elevated in hidradenitis suppurativa patients
Overall cancer risk and risk of several specific cancers was significantly higher among adults with hidradenitis suppurativa compared with...
Conference Coverage
Erythema and sclerosis predict chronic GVHD clinical response, survival
"Our findings highlight the importance of thorough skin exams in chronic GVHD patients."
From the Journals
‘The story unfolding is worrisome’ for diabetes and COVID-19
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ...
Latest News
Today’s top news highlights: Primary care practices struggle, Americans split on COVID-19 vaccine
COVID-19 puts primary care practice in peril, and social distancing takes a toll on seniors.
Latest News
New crayons reflect the global palette of skin tones
Crayola ready to release the Colors of the World in sets of 24 and 32 crayons.
Case Letter
Cutaneous Metastatic Breast Adenocarcinoma
Cutaneous metastases occur more often in the setting of breast carcinoma than other malignancies in women. The authors present the case of a...
Case Letter
Complex Regional Pain Syndrome Type II After a Brachial Plexus and C6 Nerve Root Injury
Complex regional pain syndrome (CRPS) is a neuropathic disorder of the extremities characterized by pain, a variety of autonomic and motor...
From the Journals
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.
Latest News
Today’s top news highlights: Remdesivir data dive, FDA approves contraceptive gel
FDA approves the first contraceptive gel and researchers published full results from a remdesivir trial.
Feature
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.